(Q24250191)

6 August 2017

0 references

1 reference

title

Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack (English)

1 reference

6 August 2017

1 reference

1 reference

Peter AG Sandercock

1

0 references

Orell Mielke

2

0 references

Ming Liu

3

0 references

Carl Counsell

4

0 references

P Sandercock

1

1 reference

6 August 2017

O Mielke

2

1 reference

6 August 2017

M Liu

3

1 reference

6 August 2017

C Counsell

4

1 reference

6 August 2017

20 January 2003

0 references

1 January 2003

1 reference

Cochrane Database of Systematic Reviews

6 August 2017

1 reference

6 August 2017

CD000248

1 reference

6 August 2017

1

1 reference

Trial of long-term anticoagulant therapy in the treatment of small stroke associated with a normal carotid arteriogram

6 August 2017

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Survival following stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

A long-term study of cerebral vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

A cooperative study of cerebrovascular disease; methodology and a preliminary report on the use of anticoagulants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Anticoagulant therapy in cerebral infarction. Report on cooperative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Anticoagulant therapy in cerebral thrombosis and cerebral embolism. A national cooperative study, interim report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

An evaluation of anticoagulant therapy in the treatment of cerebrovascular disease. Report of the Veterans Administration Cooperative Study of Atherosclerosis, Neruology Section

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

CEREBRAL VASCULAR DISEASE IN RELATION TO LONG-TERM ANTICOAGULANT THERAPY

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Evaluation of anticoagulants in patients with cerebral infarction with slight to moderate neurological deficit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

LONG-TERM ANTICOAGULANT THERAPY IN TRANSIENT CEREBRAL ISCHAEMIC ATTACKS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Long-term anticoagulant therapy in cerebrovascular disease: does bleeding outweigh the benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Design of ESPRIT: an international randomized trial for secondary prevention after non-disabling cerebral ischaemia of arterial origin. European/Australian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Medical therapy in patients with carotid artery stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Primary care physician-reported secondary and tertiary stroke prevention practices. A comparison between the United States and the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Why is the outcome of transient ischaemic attacks different in different groups of patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Anticoagulant therapy in cerebrovascular disease: review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Hypertension management and stroke recurrence in a community (Rochester, Minnesota, 1950-1979)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

SEPIVAC: a community-based study of stroke incidence in Umbria, Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Survival and recurrence following stroke. The Framingham study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Risk of recurrent stroke, myocardial infarction and epilepsy during long-term follow-up after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

Analysis of 30-day stroke mortality in a community-based registry in Warsaw, Poland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000248

10.1002/14651858.CD000248

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference